Deputy Director, Comprehensive Cancer Center St. Jude Children's Research Hospital Memphis, Tennessee, United States
Session Description: Genomic subcategories of acute lymphoblastic leukemia (ALL) are now recognized and incorporated into the World Health Organization and Internal Consensus Classifications. In this session, one speaker will describe the granular subclassification of ALL using powerful genomic tools such as whole transcriptome sequencing (WTS) and whole genome sequencing (WGS). The second speaker will provide a practical review of diagnostic methods, describing alternative testing approaches in settings where WTS and WGS may not be available.
If this session topic is of interest to you, please consider looking at the following course on AMP EDucation (AMPED™ Online)
Title: Application of Geospatial Techniques in Analysis of Leukemias Click here to learn more.
Learning Objectives:
Upon completion, participants will be able to define the current genomic subcategories of acute lymphoblastic leukemia.
Upon completion, participants will be able to summarize testing approaches to ALL subclassification in settings where whole trancriptome sequencing and whole genome sequencing are not currently available.
Upon completion, participants will be able to compare the relative advantages and limitations of whole transcriptome sequencing/whole genome sequencing in comparison to alternative diagnostic methods for ALL subclassification.
